PT - JOURNAL ARTICLE AU - Yekinni, Ibrahim AU - Viker, Tom AU - Hartsig, Bill AU - Erdman, Arthur TI - Formative usability assessment of a new connector design for peritoneal dialysis AID - 10.1101/2022.03.31.22273212 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.31.22273212 4099 - http://medrxiv.org/content/early/2022/04/04/2022.03.31.22273212.short 4100 - http://medrxiv.org/content/early/2022/04/04/2022.03.31.22273212.full AB - Background This paper presents a first, formative study to explore the usability of a new peritoneal dialysis connector design intended for use by patients. The study was conducted with a user population of both naive users and experienced peritoneal dialysis patients across a range of ages. The goals of the study were to evaluate the usability of the key user interfaces of this connector design by test participants representative of new and experienced peritoneal dialysis patients, as well as to evaluate the use of the connector as it interacts with other components of the peritoneal dialysis system including peritoneal dialysis fluid bags and tubing. Further objectives were to capture any usability issues and obtain participants’ feedback on the design.Methods A total of 7 patient and non-patient participants received brief training and performed simulated connection and disconnection of peritoneal catheter extension sets for therapy with the new design.Results All 7 participants completed the simulated connection and disconnection tasks successfully, with only one use error (0.22%), 18 close calls (4.0%), 6 use difficulties (1.3%) observed from the total of 449 use steps performed by all participants. Other findings include usability improvement with repeated use, participants feedback and suggestions for the ‘protective enclosure’, a novel feature of the touchless connector design.Conclusion The studied connector design showed minimal use errors or difficulties and based on participant feedback, the usability can be significantly improved with minimal modifications in future prototypes.Competing Interest StatementCompeting Interests IOY and TV invented the touchless connector. TV is an employee of Cerovations LLC, a company that has licensed the connector from the University of Minnesota for commercialization. Funding StatementResearch reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (Award Number: DK126586); National Science Foundation Division of Industrial Innovation and Partnership (Award Number 1935233); National Institutes of Health National Center for Advancing Translational Sciences (Grant UL1TR002494). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation. Additional support was provided by The Pediatric Device Innovation Consortium at the University of Minnesota. IOY was funded through the Bakken Medical Devices Center Innovation Fellowship Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the University of Minnesota waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors